Apotheek Vandervoort SA
The score of Apotheek Vandervoort shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +3 % Total assets -2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek Vandervoort's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 10,004 € | ||||
| Equity | 605,237 € | ||||
| Cash | 142,558 € | ||||
| EBITDA | 20,240 € | ||||
| Total assets | 644,949 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jun 2026
- Year ended 31 Dec 2024filed on 29 Apr 2025
- Year ended 31 Dec 2023filed on 28 May 2024
- Year ended 31 Dec 2022filed on 15 Jun 2023
- Year ended 31 Dec 2021filed on 11 May 2022
Apotheek Vandervoort's financial analysis
- Solvency93.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek Vandervoort
Apotheek Vandervoort's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0440.513.127
- VAT number
- BE0440513127
- Peppol
- Registered · 0208:0440513127 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 30 Mar 1990
- Registered office
- 2490 Balen
- Latest accounts
- 2025 · filed on 22 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek Vandervoort (SA) has been based in Balen since 1990, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 10,004 € and equity of 605,237 €; its revenue is not published. Its solvency stands at 93.8%, above the median of its sector (44.2%).
Companies similar to Apotheek Vandervoort
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Corum Retail sale of pharmaceutical products Ghent · balance sheet 641,387 €
- Mansion-Tassin Retail sale of pharmaceutical products Beyne-Heusay · balance sheet 648,936 €
- Maudens Jeroen Retail sale of pharmaceutical products Sint-Genesius-Rode · balance sheet 633,969 €
- Piret Pharma Retail sale of pharmaceutical products Charleroi · balance sheet 675,213 €
- Caro Pharma Retail sale of pharmaceutical products Erquelinnes · balance sheet 593,057 €
- MieTon Retail sale of pharmaceutical products Hoogstraten · balance sheet 705,749 €
- Emanuel - VAN Hauwermeiren Retail sale of pharmaceutical products Dendermonde · balance sheet 588,306 €
Frequently asked questions about Apotheek Vandervoort
What is the revenue of Apotheek Vandervoort?
Apotheek Vandervoort files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheek Vandervoort?
In Belgium, the VAT number is the company number prefixed with BE: BE0440513127 for Apotheek Vandervoort, if the company is VAT-registered. Its company number (CBE) is 0440.513.127.
Where is the registered office of Apotheek Vandervoort?
According to the CBE register, the registered office of Apotheek Vandervoort is in 2490 Balen.
What is the equity of Apotheek Vandervoort?
At the close of the 2025 financial year, the equity of Apotheek Vandervoort amounts to 605,237 €, a solvency of 93.8% of total assets.
Who manages Apotheek Vandervoort?
The register lists 3 active mandates at Apotheek Vandervoort. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek Vandervoort
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →